(Press-News.org) A new groundbreaking study by researchers from University of Birmingham, UCL, Great Ormond Street Hospital and Birmingham Children’s Hospital has revealed important clues into what is driving disease in children with arthritis.
Cutting-edge techniques have allowed scientists for the first time to uncover the unique architecture of cells and signals inside the joint as inflammation takes hold.
The new study published in Science Translational Medicine looks at arthritis in children, caused by the immune system mistakenly attacking joints. Juvenile idiopathic arthritis affects more than 10,000 children in the UK. It causes swelling, stiffness and pain in the joints over years or decades, leading to damage of the joints and long-term disability. Whilst treatments are available to manage the condition, and in some cases achieve remission, there is no cure. It can take time to find which treatment works for each person. Treatments don’t work in the same way for every child, suggesting there are hidden differences between individuals that we are only beginning to understand.
Deepening the scientific and clinical community’s understanding of the condition is vital if more effective treatments are to be found, and undertaking biopsies in young children provides a new way forward. Working with families of children with arthritis opened the door to this study, as the families advocated for the potential of the study, agreeing that the procedure would be acceptable to families, especially compared to living with a chronic inflammatory disease.
In a world first, tiny tissue samples were collected from the joint lining when children were having medicine injected into the joint. These samples were then analysed with advanced imaging and gene-profiling technologies. The fine resolution maps of the joints revealed differences between children of different ages and cell changes in those with more severe disease. These unique cellular fingerprints may help researchers understand why some drugs work better for some children, and not others. The joints of children with arthritis looked significantly different to those with adults, demonstrating the need to understand arthritis in children better.
Professor Adam Croft, Versus Arthritis Professor of Rheumatology at the University of Birmingham and chief investigator of the study said:
“We know how frustrating it can be for families and young people to find a drug that best works for their arthritis. Finding ways to better predict which medicines will be beneficial for a particular child would mean we were able to treat the disease more rapidly and effectively. To achieve this goal, we first needed to understand what cells make-up the lining of the joint where the inflammation occurs.
"Equipped with that knowledge, we can now start to tackle the next challenge, determining how these cellular fingerprints within the joint tissue can help us predict which drug will work best, ensuring we give the right drug, to the right child, at the right stage of their disease.”
One of the children who took part in the study was Aurelia, from London, who was diagnosed with arthritis after injuring her knee while on holiday.
“Aurelia is a sporty child and loves art, drama, music and ballet. We noticed pain and swelling of her knee whilst on holiday. We thought perhaps she had injured it playing, but when this didn't get better and she was struggling to walk, we realised something else was wrong. She was referred to the Rheumatology team at Great Ormond Street Hospital who diagnosed her with arthritis. This came as a bit of a shock given how active she is!
“They offered her a steroid injection in her knee under general anaesthetic to alleviate the symptoms. The team asked if we were happy for her to take part in this research study and collect some tissue samples at the same time.
“We were keen for her to be involved, as there’s still a lot of unknowns with arthritis in children, and not all treatments can work. Given that she was already having an anaesthetic, and it wasn’t an additional operation for her, it was a great opportunity for researchers to take samples and to be better able to study the conditions. We hope the study will help other families with children in similar positions to us,” explained Aurelia’s mum, Emily.
Professor Lucy Wedderburn, University College London Great Ormond Street Institute of Child Health and Consultant of Paediatric Rheumatology at Great Ormond Street Hospital said:
“This study represents a real step change in our work with children and young people who live with arthritis, and has been a huge team effort. Rather than having to rely on blood tests which often do not tell us accurately what is happening in the joint, we can now directly analyse the joint lining, across different types of childhood arthritis and different ages. Our findings show that younger children have different types of immune cells invading their joints compared to older children. Samples from children with arthritis looked different to adult samples, with a different make up of immune cells, blood vessels and distinct connective tissue cells. This suggests that treatments may need to vary depending on age and shows why we can’t just extend studies from adult studies to understand arthritis in children.”
The study was funded by the Medical Research Council, Versus Arthritis, National Institute of Health and Care Research, Great Ormond Street Hospital Charity, amongst others, and delivered through the National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre (BRC).
Lucy Donaldson, Director of Research at Versus Arthritis said:
“People with arthritis should never be reduced to just their condition. Each person deserves to be treated holistically as an individual, including, of course, children and young people with arthritis.
“We are very proud to invest in truly innovative research like the MAPJAG study which is helping us to better understand the individual differences between young people with juvenile arthritis.
“The MAPJAG team’s findings clearly show that children and young people aren't just small adults, but have a different "cellular fingerprint". Importantly the team have also shown that this can change with age. The findings can give real hope to all those families that more can be done, sooner, to enable young people with arthritis to live the lives they choose.”
A wider programme of work, made possible by a Medical Research Council partnership award known as Tissue Research in Childhood Arthritis (TRICIA), supports the infrastructure needed for multi-centre tissue research of the joint. In future, it is hoped that a larger study, involving more centres will allow researchers to dig deeper into the remaining questions about how best to tailor treatments for individual patients.
Instrumental to driving this research forward was Dr Eslam Al-Abadi, a study investigator from the Birmingham Women’s and Children’s Hospital NHS Foundation Trust, who sadly passed away before publication. His incredible efforts in seeking to improve the care of children with this disease are gratefully acknowledged.
END
First of its kind study for children with arthritis reveals possible new disease targets
Researchers have been able to see what happens in the inflamed joints of children with arthritis, giving insight into why treatments affect children differently
2025-07-02
ELSE PRESS RELEASES FROM THIS DATE:
Financing innovation: proposal for novel adaptive platform trial fund offers new model for ALS drug development
2025-07-02
A team of researchers from the MIT Sloan School of Management, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), Questrom School of Business at Boston University, and QLS Advisors have introduced a new approach to funding clinical trials for amyotrophic lateral sclerosis (ALS) therapies. The study “Financing Drug Development via Adaptive Platform Trials,” published today in PLOS One, outlines a financing model that merges the efficiencies of adaptive platform trials — lower costs and shorter durations — with an innovative royalty-based investment structure designed to accelerate therapeutic development ...
Disparities in treatment and referral after an opioid overdose among emergency department patients
2025-07-02
About The Study: In this study, Black patients were less likely to receive outpatient referrals for opioid use disorder. These findings underscore the need for targeted interventions to address racial disparities in emergency department care for opioid use disorder, particularly in enhancing referral processes.
Corresponding Author: To contact the corresponding author, Siri Shastry, MD, MS, email Siri.Shastry@mountsinai.org.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.18569)
Editor’s Note: Please ...
Was Mars doomed to be a desert? Study proposes new explanation
2025-07-02
One of the great unsolved problems in modern planetary science is written on the surface of Mars.
Mars has canyons that were carved by rivers, so it was once warm enough for liquid water. How—and why—did it become it a barren desert today?
A study led by University of Chicago planetary scientist Edwin Kite puts forth a new explanation for why Mars never seems to stay balmy for long. Published July 2 in Nature, their model suggests that the periods of liquid water we see in the past were initiated by the sun brightening, and that conditions on Mars mean it ...
Study highlights major hurdles for multinational clinical trials in Europe
2025-07-02
Study Highlights Major Hurdles for Multinational Clinical Trials in Europe
A new study by investigators from Europe, including the Netherlands and the United Kingdom (UK), has shed light on significant ethical, administrative, regulatory, and logistical (EARL) hurdles in delivering multinational randomized clinical trials. The research was the first to comprehensively quantify these barriers for an international platform trial and emphasizes the need for urgent improvements, particularly in preparing for future public health crises.
Randomized controlled trials provide the highest level of evidence to inform medical practice. Yet, delivering such trials ...
Chemistry breakthrough has potential to make more effective cancer drugs with less harmful side effects
2025-07-02
Chemists have discovered for the first time a unique way to control and modify a type of compound widely used in medicines, including a drug used to treat breast cancer.
The research, led by the University of Bristol and published today in the journal Nature, also found a new mechanism associated with the chemical reaction which enables the shape of the compound to be flipped from being right-handed to left-handed by simply adding a common agent in the chemical reaction.
Study lead author Varinder Aggarwal, Professor of Synthetic Chemistry at the University of Bristol, said: “The findings change our understanding of the fundamental chemistry of this group of organic ...
Researchers identify new protein target to control chronic inflammation
2025-07-02
Chronic inflammation occurs when the immune system is stuck in attack-mode, sending cell after cell to defend and repair the body for months or even years. Diseases associated with chronic inflammation, like arthritis or cancer or autoimmune disorders, weigh heavily on human health—and experts anticipate their incidence is on the rise. A new study by investigators from Mass General Brigham identified a protein called WSTF that could be targeted to block chronic inflammation. Crucially, this strategy would not ...
Increasing contingency management incentives will help more patients recover from addiction
2025-07-02
Early recovery from drug addiction to opioids and stimulants is physically and mentally demanding, and a long road to recovery.
“During the early stages of addiction recovery there is typically not much that is positive for patients,” shares behavioral health counselor Carla J. Rash, Ph.D. of UConn School of Medicine. “But Contingency Management is an effective, behavioral tool bringing some early-on positivity to a patient’s addiction recovery treatment plan until the positive benefits of their medication and body’s natural recovery kicks-in.”
Rash adds, “Essentially, ...
Changes in the blood could protect against Alzheimer’s disease
2025-07-02
A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset Alzheimer’s disease.
A team led by researchers at Baylor College of Medicine discovered that both a mouse model and people carrying blood stem cells with mutations in the gene TET2, but not in the gene DNMT3A, had a lower risk for developing Alzheimer’s disease. Their study proposes a mechanism that can protect against the disease and opens new avenues for potential strategies to control the emergence ...
New tool allows researchers to track assembly of cells’ protein-making machines
2025-07-02
Proteins are the infinitely varied chemicals that make cells work, and science has a pretty good idea how they are made. But a critical aspect underlying the machinery of protein manufacture has long been hidden inside a blobby cellular structure called the nucleolus.
Now, a team of Princeton engineers have developed a technique to peer inside the nucleolus and reveal this hidden system of creation. Previous methods required researchers to break open the cell and destroy most of its structures, resulting in minimal access to the blob’s inner workings. By tracking the movement of RNA molecules inside the nucleolus using advanced imaging and genomics techniques, ...
New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers
2025-07-02
Ovarian clear cell carcinoma is difficult to treat, and treatment options are limited
Patients with specific PPP2R1A mutations in their tumors survived significantly longer after immunotherapy treatment
Targeting PPP2R1A may improve responses even further according to laboratory studies
PPP2R1A is an important predictive biomarker and possible treatment target for multiple cancer types, study found
HOUSTON, JULY 2, 2025 ― Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found ...
LAST 30 PRESS RELEASES:
Enhancing the “feel-good” factor of urban vegetation using AI and street view images
A single genetic mutation may have made humans more vulnerable to cancer than chimpanzees
Innovative nanocomposite hydrogel shows promise for cartilage regeneration in osteoarthritis treatment
2025 Guangci Laboratory Medicine Innovation and Development Conference
LabMed Discovery is included in the ICI World Journals database
LabMed Discovery is included in the China Open Access Journal (COAJ) database
Vaccination support program reduces pneumonia-related mortality by 25 percent among the elderly
Over decades, a healthy lifestyle outperforms metformin in preventing onset of Type 2 diabetes
Mental health disorders, malaria, and heart disease most affected by covid pandemic
Green transition will boost UK productivity
Billions voted in 2024, but major new report exposes cracks in global democracy
Researchers find “forever chemicals” impact the developing male brain
Quantum leap in precision sensing across technologies
Upgrading biocrude oil into sustainable aviation fuel using zeolite-supported iron-molybdenum carbide nanocatalysts
For effective science communication, ‘just the facts’ isn’t good enough
RT-EZ: A golden gate assembly toolkit for streamlined genetic engineering of rhodotorula toruloides
Stem Cell Reports announces five new early career editors
Support networks may be the missing link for college students who seek help for excessive drinking
The New England Journal of Medicine shines spotlight on forensic pathology
Scientists discover protein that helps lung cancer spread to the brain
Perceived social status tied to cardiovascular risks in women but not in men
Brain tumor growth patterns may help inform patient care management
This might be America's first campus tree inventory
Emoji use may impact relationship outcomes
Individual merit, not solidarity, prioritized by early childhood education policies
Preclinical study unlocks a mystery of rapid mouth healing
Extraterrestrial habitats: bioplastics for life beyond earth
U.S. military spending reductions could substantially lower energy consumption
Air pollution is linked to adverse birth outcomes in India
Using viral load tests to help predict mpox severity when skin lesions first appear
[Press-News.org] First of its kind study for children with arthritis reveals possible new disease targetsResearchers have been able to see what happens in the inflamed joints of children with arthritis, giving insight into why treatments affect children differently